SenseToKnow Autism Screening Device Validation Study
Duke University · with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT05874466
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 1–3 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 350
- US sites recruiting
- 1
- Study start
- July 7, 2023
- Record last updated
- March 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a pivotal, prospective, double-blind, study to evaluate the sensitivity and specificity of the SenseToKnow device for the detection of autism spectrum disorder in children 16-36 months of age.
Conditions: Autism; Autism Spectrum Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Duke Health pediatric patient at enrollment
- 16-\<37 months of age at enrollment
- Parent/legal guardian speaks English or Spanish
- Parent/legal guardian understands and voluntarily provides informed consent
Exclusion Criteria
- Severe motor impairment that precludes study measure completion
- Known genetic disorders
- Severe hearing or visual impairment as determined on physical examination according to parent report
- Acute illnesses likely to prevent successful or valid data collection
- Uncontrolled epilepsy or seizure disorder
- History or presence of a clinically significant medical disease, or a mental state that could confound the study or be detrimental to the subject as determined by the investigator
- Acute exacerbations of chronic illnesses likely to prevent successful or valid data collection
- Receiving therapies that affect vision
- Parent/legal guardian and/or investigator believes that the child will be unable/unwilling to sit in the parent's lap to watch the app videos
- Parent/legal guardian indicates that they or their child is unwilling or unable to complete the app administration, surveys, or diagnostic assessment
- Participants who are otherwise judged as unable to comply with the protocol by the investigator
- Any other factor that the investigator feels would make the study measures invalid
Recruiting US locations
Duke University
Durham, NC 27705
Site contact: Geraldine Dawson, PhD · 919-668-0070
Study contacts (from the official record)
- Geraldine Dawson, PhD · 9196680070 · geraldine.dawson@duke.edu
- Charlotte Stoute, BA · 919-681-9730 · charlotte.stoute@duke.edu
Similar studies in North Carolina
All healthy volunteers studies in North Carolina →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Nalmefene Implant in Healthy Subjects
ReacX Pharmaceuticals, Inc.
- Location
- Morrisville, NC
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
University of North Carolina, Chapel Hill
- Location
- Chapel Hill, NC + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Breastfeeding Intervention to Prevent Obesity Among Children
University of North Carolina, Greensboro
- Location
- Greensboro, NC + 1 other US site
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Charlotte, NC + 7 other US sites
- Eligibility basics
- Ages 12–55